Healix

Clostridium difficile-Associated Diarrhea Incidence and Outcomes for Patients Treated with Intravenous Antibiotics in Infectious Disease Physician Office Infusion Centers (POICs)

Authors:
Ramesh V. Nathan, MD – Mazur, Statner, Dutta, Nathan, PC, Thousand Oaks, CA
Barry Statner, MD – Mazur, Statner, Dutta, Nathan, PC, Thousand Oaks, CA
Philip S. Brachman, MD – Atlanta ID Group, PC, Atlanta, GA
Andrew H. Krinsky, MD – Infectious Disease Associates, Sarasota, FL
Robin H. Dretler, MD – Infectious Disease Specialists of Atlanta, Atlanta, GA
Lucinda J. Van Anglen, PharmD – Healix Infusion Therapy, Inc. Sugar Land, TX

View Poster

View All

Phase II and Phase III Studies

Healix regularly and actively supports Phase II and Phase III clinical trials in each of our specialty areas, including active studies in Multiple Sclerosis and Intestinal Bowel Disease.

For information on partnering with Healix on a study, please contact us.

FacebookTwitterLinkedInarrow1arcsearchiconowdtnotfound